1. Home
  2. CURI vs LPTX Comparison

CURI vs LPTX Comparison

Compare CURI & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CURI
  • LPTX
  • Stock Information
  • Founded
  • CURI N/A
  • LPTX 2011
  • Country
  • CURI United States
  • LPTX United States
  • Employees
  • CURI N/A
  • LPTX N/A
  • Industry
  • CURI Movies/Entertainment
  • LPTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CURI Consumer Discretionary
  • LPTX Health Care
  • Exchange
  • CURI Nasdaq
  • LPTX Nasdaq
  • Market Cap
  • CURI 144.8M
  • LPTX 119.6M
  • IPO Year
  • CURI N/A
  • LPTX N/A
  • Fundamental
  • Price
  • CURI $3.17
  • LPTX $0.36
  • Analyst Decision
  • CURI Strong Buy
  • LPTX Buy
  • Analyst Count
  • CURI 1
  • LPTX 2
  • Target Price
  • CURI $3.00
  • LPTX $8.00
  • AVG Volume (30 Days)
  • CURI 204.0K
  • LPTX 6.0M
  • Earning Date
  • CURI 05-06-2025
  • LPTX 05-12-2025
  • Dividend Yield
  • CURI 2.82%
  • LPTX N/A
  • EPS Growth
  • CURI N/A
  • LPTX N/A
  • EPS
  • CURI N/A
  • LPTX N/A
  • Revenue
  • CURI $51,134,000.00
  • LPTX N/A
  • Revenue This Year
  • CURI $14.96
  • LPTX N/A
  • Revenue Next Year
  • CURI $10.06
  • LPTX N/A
  • P/E Ratio
  • CURI N/A
  • LPTX N/A
  • Revenue Growth
  • CURI N/A
  • LPTX N/A
  • 52 Week Low
  • CURI $0.94
  • LPTX $0.22
  • 52 Week High
  • CURI $3.22
  • LPTX $4.79
  • Technical
  • Relative Strength Index (RSI)
  • CURI 64.78
  • LPTX 45.27
  • Support Level
  • CURI $2.30
  • LPTX $0.22
  • Resistance Level
  • CURI $2.71
  • LPTX $0.38
  • Average True Range (ATR)
  • CURI 0.23
  • LPTX 0.05
  • MACD
  • CURI 0.03
  • LPTX 0.02
  • Stochastic Oscillator
  • CURI 91.68
  • LPTX 89.24

About CURI CuriosityStream Inc.

CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions, and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.

About LPTX Leap Therapeutics Inc.

Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .

Share on Social Networks: